gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · USNAHealthcarePharmaceuticals

USANA Health Sciences Inc (USNA)

$14.33−3.63%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$14.87▼ 30.02% in range
Nov 3, 2025Low $12.86 · High $23.24Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

USANA Health Sciences closed at $14.33 on Nov 4, down 3.63%, 38.3% below its 52-week closing high. Volume of 303.9K shares was 1.62× its 20-day average (above normal).

Split-adjusted performance: -3.4% over one month, -28.4% over six months, -32.6% over one year.

In the quarter ended Jul 4, 2026, revenue was $223.27M, down 5.3% from a year earlier, with a net margin of -9.6%.

Short interest was 779.0K shares at the Oct 15 settlement (7.2% of float, 4.4 days to cover).

Market cap$264.8M18.5M shares
Revenue · quarter$223.3M−5.3% YoY
Diluted EPS$-1.16−323.1% YoY
P/E · TTM—P/S 0.3×
Net margin-9.6%Gross 78.3%
Dividend yieldNone
52-week range12.86 – 23.24−38.3% from high
Volume303.9K1.62× 20-day avg
Volatility · 60d34.7%Annualised
Short % of float7.2%4.4 days to cover
Net cash$168.6MCash $168.6M
Next earnings—Not scheduled
Split-adjusted performance
1W −2.0%1M −3.4%3M −3.8%6M −28.4%YTD −27.0%1Y −32.6%3Y −69.0%5Y −84.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum47
Revenue growth36
Net margin63
Value (low P/E)—
Size52

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short779.0K+1.0% vs prior
Days to cover4.4Settled Oct 15
% of float7.2%
Short vol. 10d52.2%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
USNAUSANA Health Sciences$14.33−3.63%−28.4%−5.3%−9.6%—$264.8M
QTTBQ32 Bio$8.97+2.40%+64.0%——7.9$267.0MCompare
BIOABioAge Labs$5.95−0.17%−67.8%+1.6%−1064.7%—$273.1MCompare
KRROKorro Bio$16.62+4.79%+24.6%−100.0%——$244.7MCompare
RCKTRocket Pharmaceuticals$2.61+3.98%−32.4%———$286.5MCompare
LRMRLarimar Therapeutics$2.76+8.66%−33.5%———$286.7MCompare
LFCRLifecore Biomedical$6.44+0.31%+29.8%—−20.9%—$244.1MCompare
IMRXImmuneering$3.76+2.17%−27.6%———$243.5MCompare
FULCFulcrum Therapeutics$3.77+0.80%−47.0%———$288.0MCompare

News about USANA Health Sciences

All news →
USANA Health Sciences (USNA) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research · 1d ago▼ NegativeWhy Usana Health Sciences Stock Plummeted This WeekThe Motley Fool · Aug 9, 2026▼ Negative

Quick answers

What does USANA Health Sciences do?
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness.
What is USNA's market cap?
$264.77M, based on the Nov 4 close of $14.33.
Does USANA Health Sciences pay a dividend?
No regular cash dividend has been paid in the last year.
How much of USNA is sold short?
779.0K shares, 7.2% of float, as of Oct 15, 2026.
What sector is USNA in?
Healthcare, in the Pharmaceuticals industry.

About USANA Health Sciences

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

HQ: Salt Lake City, UT1,570 employeesListed Apr 22, 1993usana.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology